UNSPSC 51285205: Trimethoprim pamoate

This classification denotes the pamoate form of a urinary anti-infective agent with the molecular formula C14H18N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AN164J8Y0X, chemically known as 2,4-pyrimidinediamine, 5-((3,4,5-trimethoxyphenyl)methyl)- but more generally known as trimethoprim, which bears US NIH Compound Identifier 5578. European Medicines Agency schedules Trimethoprim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11310MIG.

UNSPSC 51285205 Trimethoprim pamoate is a Commodity code for a specific pharmaceutical product, but the recent state and local opportunities tagged under this code show minimal alignment with the nominal scope. The two most recent records—an Illinois Department of Public Health piggyback pharmaceutical contract awarded to Chartwell Rx LLC in August 2026 for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, and a Seminole County, Florida procurement for Naloxone and Safe Drug Deactivation Systems—do not reference trimethoprim pamoate or closely related pharmaceuticals. State and local health departments, counties, and community health agencies do source pharmaceuticals through cooperative purchasing vehicles and IFB processes, typically with annual terms and renewal options, but the available records do not demonstrate current demand for this specific commodity under this code.

The geographic spread of activity shown includes Illinois and Florida, though the sample is too limited to characterize broader regional concentration. The Illinois award, posted August 28, 2026 with response deadline September 11, 2026, used an Invitation for Bid process through the MMCAP Infuse consortium, a common cooperative purchasing vehicle for state pharmaceutical procurement. The Seminole County opportunity, posted June 30, 2026, was an IFB with a July 26, 2023 response date and required quarterly deliveries to a county health facility. No recent solicitations in the available block specifically reference trimethoprim pamoate or close pharmaceutical analogues, suggesting this code may see limited recent activity or may be mismatched to current state and local pharmaceutical sourcing patterns.